CRVS logo

Corvus Pharmaceuticals (CRVS)

Profile

Full Name

Corvus Pharmaceuticals, Inc.

Ticker Symbol

CRVS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 23, 2016

Indexes

Not included

Website

http://www.corvuspharma.com

Employees

31

Key Details

Price

$2.98(+3.83%)

Market cap

$203.04M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.02(-82.14% YoY)

PE ratio

-

Next earnings date

May 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.98
CRVS price is $2.98

30-Day Relative Volume

0.63
CRVS 30-day relative volume is 0.63

Price Performance

Price Most recent change

+3.83%
CRVS price was up +3.83% on Apr 11, 2025

Price YTD change

-44.3%
CRVS price is down -44.3% since January 1st

Price 1-year change

+91.03%
CRVS price is up +91.03% year-on-year

Price 3-year change

+88.61%
CRVS price is up +88.61% over the past 3 years

Price Range

Price All-time high

$22.14
CRVS price is currently -86.54% below its historical high of $22.14

Price 3-year low

$0.61
CRVS price is currently +390.94% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$203.04M
CRVS market capitalization is $203.04 million

Market cap 3-year change

+176.05%
CRVS market capitalization is up +176.05% over the past 3 years

Market cap All-time high

$608.52M
CRVS market capitalization is currently -66.63% below its historical high of $608.52 million

Market cap sector rank

58.18%
CRVS market capitalization is higher than 58.18% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+38.94%
CRVS shares outstanding is up +38.94% year-on-year

Shares Outstanding 3-Year Change

+46.36%
CRVS shares outstanding is up +46.36% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.41
CRVS beta is 1.41

200-day SMA

$5.11
CRVS price is currently -41.70% below its 200-day simple moving average

50-day SMA

$4.17
CRVS price is currently -28.57% below its 50-day simple moving average

RSI

33.04
CRVS 14-day relative strength index is 33.04

Volume

0.63
CRVS 30-day relative volume is 0.63

ATR

$0.32
CRVS average true range is $0.32

10-day Historical Volatility

63.54%
CRVS 10-day historical volatility is 63.54%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
CRVS annual revenue value is unknown

Revenue Analysts estimate

-
CRVS annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
CRVS annual revenue 1-year change is unknown

Revenue Sector rank

-
CRVS annual revenue is unknown

EPS

EPS

-$1.02
CRVS annual earnings per share is -$1.02

EPS Analysts estimate

-$0.46
CRVS annual earnings per share is currently +119.83% higher than the consensus analysts' forecast

EPS 1-year change

-82.14%
CRVS annual earnings per share is down -82.14% year-on-year

EPS Sector rank

56.4%
CRVS annual earnings per share is higher than 56.4% of companies in Healthcare sector

Profit

Gross profit

-
CRVS annual gross profit value is unknown

Gross margin

-
CRVS annual gross profit margin value is unknown

Operating profit

-$27.55M
CRVS annual operating income is -$27.55 million

Operating margin

-
CRVS annual operating profit margin value is unknown

Net income

-$62.29M
CRVS annual net profit is -$62.29 million

Net margin

-
CRVS annual net profit margin value is unknown

Expenses

Total expenses

$27.55M
CRVS annual total expenses is $27.55 million

Operating expenses

$27.55M
CRVS annual total operating expenses is $27.55 million

Cost of goods sold

-
CRVS annual cost of goods sold value is unknown

Selling, general & administrative expenses

$8.16M
CRVS annual SGA is $8.16 million

Depreciation and amortization

$85.00K
CRVS annual depreciation & amortization is $85.00 thousand

Interest expense

-
CRVS annual interest expense value is unknown

Income tax

-
CRVS annual income tax value is unknown

EBIT & EBITDA

EBIT

-$27.55M
CRVS annual earnings before interest & taxes is -$27.55 million

EBITDA

-$27.46M
CRVS annual EBITDA is -$27.46 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$68.91M
CRVS annual total assets is $68.91 million

Non current assets

$14.50M
CRVS annual long term assets is $14.50 million

Current assets

$54.41M
CRVS annual total current assets is $54.41 million

Cash and cash equivalents

$8.74M
CRVS annual cash & cash equivalents is $8.74 million

Accounts receivable

$75.00K
CRVS annual accounts receivable is $75.00 thousand

Inventory

-
CRVS annual inventory value is unknown

Liabilities

Total liabilities

$36.34M
CRVS annual total liabilities is $36.34 million

Long term liabilities

$937.00K
CRVS annual total long term liabilities is $937.00 thousand

Current liabilities

$35.40M
CRVS annual total current liabilities is $35.40 million

Accounts payable

$2.58M
CRVS annual accounts payable is $2.58 million

Debt

Total debt

$1.12M
CRVS annual total debt is $1.12 million

Total debt 1-year change

-18.34%
CRVS annual total debt is down -18.34% year-on-year

Long term debt

$937.00K
CRVS annual long term debt is $937.00 thousand

Short term debt

$185.00K
CRVS annual short term debt is $185.00 thousand

Equity & Capital

Shareholders equity

$32.57M
CRVS annual stockholders equity is $32.57 million

Book value

$32.57M
CRVS annual book value is $32.57 million

Retained earnings

-$397.01M
CRVS annual retained earnings is -$397.01 million

Working capital

$19.00M
CRVS annual working capital is $19.00 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$25.42M
CRVS annual cash flow from operations is -$25.42 million

Cash from operations 1-year change

-6.22%
CRVS annual cash flow from operations is down -6.22% year-on-year

Cash from investing

-$27.48M
CRVS annual cash flow from investing activities is -$27.48 million

Cash from investing 1-year change

-276.85%
CRVS annual cash flow from investing activities is down -276.85% year-on-year

Cash from financing

$49.03M
CRVS annual cash flow from financing activities is $49.03 million

Cash from financing 1-year change

+524.16%
CRVS annual cash flow from financing activities is up +524.16% year-on-year

CAPEX

CAPEX

-
CRVS annual capital expenditures value is unknown

CAPEX 1-year change

-
CRVS annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$25.42M
CRVS annual free cash flow is -$25.42 million

Free cash flow 1-year change

-6.07%
CRVS annual free cash flow is down -6.07% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
CRVS annual gross profit margin value is unknown

Operating margin

-
CRVS annual operating profit margin value is unknown

Net margin

-
CRVS annual net profit margin value is unknown

ROA & ROE

ROA

-90.40%
CRVS annual return on assets is -90.40%

ROE

-191.27%
CRVS annual return on equity is -191.27%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CRVS price to earnings ratio value is unknown

PE ratio Sector rank

-
CRVS price to earnings ratio is unknown

PB Ratio

PB ratio

6.23
CRVS price to book ratio is 6.23

PB ratio Sector rank

86.84%
CRVS price to book ratio is higher than 86.84% of companies in Healthcare sector

PS Ratio

PS ratio

-
CRVS price to sales ratio value is unknown

PS ratio Sector rank

-
CRVS price to sales ratio is unknown

Enterprise value

Enterprise value

$195.43M
CRVS enterprise value is $195.43 million

Enterprise value Sector rank

59.21%
CRVS enterprise value is higher than 59.21% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-7.12
CRVS EV/EBITDA is -7.12

EV/EBITDA Sector rank

13.99%
CRVS EV/EBITDA is higher than 13.99% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.54
CRVS annual current ratio is 1.54

Quick ratio

-
CRVS annual quick ratio value is unknown

Leverage

Debt to equity

0.03
CRVS annual debt to equity ratio is 0.03

Interest coverage ratio

-
CRVS annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
CRVS piotroski f-score value is unknown

Altman Z-Score

-
CRVS altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 26, 25 Oppenheimer
Outperform
Mar 26, 25 HC Wainwright & Co.
Buy
Jan 14, 25 HC Wainwright & Co.
Buy
Jan 2, 25 HC Wainwright & Co.
Buy
Nov 13, 24 Oppenheimer
Outperform
Sep 16, 24 Ladenburg Thalmann
Buy
May 7, 24 Oppenheimer
Outperform
Apr 1, 24 Cantor Fitzgerald
Overweight
Mar 27, 24 Mizuho
Neutral
Mar 20, 24 Oppenheimer
Outperform

Institutional Ownership

Similar stocks

DRUG logo
Bright Minds Biosciences (DRUG)
enGene Holdings (ENGN)
ESPR logo
Esperion Therapeutics (ESPR)
QTRX logo
Quanterix (QTRX)
OCGN logo
Ocugen (OCGN)
DBVT logo
DBV Technologies SA (DBVT)
PDEX logo
Pro-Dex (PDEX)
CDTX logo
Cidara Therapeutics (CDTX)
TVGN logo
Tevogen Bio Holdings (TVGN)
  • What is the ticker symbol for Corvus Pharmaceuticals?
  • Does Corvus Pharmaceuticals pay dividends?
  • What sector is Corvus Pharmaceuticals in?
  • What industry is Corvus Pharmaceuticals in?
  • What country is Corvus Pharmaceuticals based in?
  • When did Corvus Pharmaceuticals go public?
  • Is Corvus Pharmaceuticals in the S&P 500?
  • Is Corvus Pharmaceuticals in the NASDAQ 100?
  • Is Corvus Pharmaceuticals in the Dow Jones?
  • When was Corvus Pharmaceuticals's last earnings report?
  • When does Corvus Pharmaceuticals report earnings?
  • Should I buy Corvus Pharmaceuticals stock now?

What is the ticker symbol for Corvus Pharmaceuticals?

The ticker symbol for Corvus Pharmaceuticals is NASDAQ:CRVS

Does Corvus Pharmaceuticals pay dividends?

No, Corvus Pharmaceuticals does not pay dividends

What sector is Corvus Pharmaceuticals in?

Corvus Pharmaceuticals is in the Healthcare sector

What industry is Corvus Pharmaceuticals in?

Corvus Pharmaceuticals is in the Biotechnology industry

What country is Corvus Pharmaceuticals based in?

Corvus Pharmaceuticals is headquartered in United States

When did Corvus Pharmaceuticals go public?

Corvus Pharmaceuticals's initial public offering (IPO) was on March 23, 2016

Is Corvus Pharmaceuticals in the S&P 500?

No, Corvus Pharmaceuticals is not included in the S&P 500 index

Is Corvus Pharmaceuticals in the NASDAQ 100?

No, Corvus Pharmaceuticals is not included in the NASDAQ 100 index

Is Corvus Pharmaceuticals in the Dow Jones?

No, Corvus Pharmaceuticals is not included in the Dow Jones index

When was Corvus Pharmaceuticals's last earnings report?

Corvus Pharmaceuticals's most recent earnings report was on Mar 25, 2025

When does Corvus Pharmaceuticals report earnings?

The next expected earnings date for Corvus Pharmaceuticals is May 6, 2025

Should I buy Corvus Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page